151 related articles for article (PubMed ID: 33002285)
1. Clinicopathological significance of intelectin-1 in colorectal cancer: Intelectin-1 participates in tumor suppression and favorable progress.
Katsuya N; Sentani K; Sekino Y; Yamamoto Y; Kobayashi G; Babasaki T; Oue N; Amatya VJ; Takeshima Y; Yasui W
Pathol Int; 2020 Dec; 70(12):943-952. PubMed ID: 33002285
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of SPC18 in colorectal cancer: SPC18 participates in tumor progression.
Hattori T; Sentani K; Naohide O; Sakamoto N; Yasui W
Cancer Sci; 2017 Jan; 108(1):143-150. PubMed ID: 27859949
[TBL] [Abstract][Full Text] [Related]
3. Intelectin 1 suppresses tumor progression and is associated with improved survival in gastric cancer.
Li D; Zhao X; Xiao Y; Mei H; Pu J; Xiang X; Jiao W; Song H; Qu H; Huang K; Zheng L; Tong Q
Oncotarget; 2015 Jun; 6(18):16168-82. PubMed ID: 25965823
[TBL] [Abstract][Full Text] [Related]
4. ITLN1 inhibits tumor neovascularization and myeloid derived suppressor cells accumulation in colorectal carcinoma.
Chen L; Jin XH; Luo J; Duan JL; Cai MY; Chen JW; Feng ZH; Guo AM; Wang FW; Xie D
Oncogene; 2021 Oct; 40(40):5925-5937. PubMed ID: 34363021
[TBL] [Abstract][Full Text] [Related]
5. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin and Intelectin-1: Important Adipokine Players in Obesity-Related Colorectal Carcinogenesis.
Kawashima K; Maeda K; Saigo C; Kito Y; Yoshida K; Takeuchi T
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422056
[TBL] [Abstract][Full Text] [Related]
7. Joint analysis of left ventricular expression and circulating plasma levels of Omentin after myocardial ischemia.
Saddic LA; Nicoloro SM; Gupta OT; Czech MP; Gorham J; Shernan SK; Seidman CE; Seidman JG; Aranki SF; Body SC; Fitzgibbons TP; Muehlschlegel JD
Cardiovasc Diabetol; 2017 Jul; 16(1):87. PubMed ID: 28687077
[TBL] [Abstract][Full Text] [Related]
8. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer.
Mukai S; Oue N; Oshima T; Mukai R; Tatsumoto Y; Sakamoto N; Sentani K; Tanabe K; Egi H; Hinoi T; Ohdan H; Yasui W
Ann Surg Oncol; 2017 Feb; 24(2):594-602. PubMed ID: 26832883
[TBL] [Abstract][Full Text] [Related]
10. Association of Intelectin 1 Gene rs2274907 A > T Polymorphism with Obesity, Type 2 Diabetes, Serum Intelectin-1 Levels and Lipid Profiles in Turkish Adults.
Guclu-Geyik F; Koseoglu P; Guven G; Can G; Kaya A; Coban N; Komurcu-Bayrak E; Erginel-Unaltuna N
Biochem Genet; 2023 Dec; 61(6):2276-2292. PubMed ID: 37020118
[TBL] [Abstract][Full Text] [Related]
11. The Emerging Role of Intelectin-1 in Cancer.
Paval DR; Di Virgilio TG; Skipworth RJE; Gallagher IJ
Front Oncol; 2022; 12():767859. PubMed ID: 35186726
[TBL] [Abstract][Full Text] [Related]
12. Intelectin1 ameliorates macrophage activation via inhibiting the nuclear factor kappa B pathway.
Kobayashi H; Uchimura K; Ishii T; Takahashi K; Mori K; Tsuchiya K; Furuya F
Endocr J; 2022 May; 69(5):539-546. PubMed ID: 34866068
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an intelectin-1 (
Nonnecke EB; Castillo PA; Akahoshi DT; Goley SM; Bevins CL; Lönnerdal B
Front Immunol; 2022; 13():894649. PubMed ID: 36072603
[TBL] [Abstract][Full Text] [Related]
14. Arginine ADP-ribosyltransferase 1 promotes angiogenesis in colorectal cancer via the PI3K/Akt pathway.
Yang L; Xiao M; Li X; Tang Y; Wang YL
Int J Mol Med; 2016 Mar; 37(3):734-42. PubMed ID: 26847718
[TBL] [Abstract][Full Text] [Related]
15. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
16. The association of Val109Asp polymorphic marker of intelectin 1 gene with abdominal obesity in Kyrgyz population.
Isakova J; Talaibekova E; Vinnikov D; Aldasheva N; Mirrakhimov E; Aldashev A
BMC Endocr Disord; 2018 Feb; 18(1):15. PubMed ID: 29482534
[TBL] [Abstract][Full Text] [Related]
17. The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways.
Tian XY; Li J; Liu TH; Li DN; Wang JJ; Zhang H; Deng ZL; Chen FJ; Cai JP
Cancer Med; 2020 Nov; 9(22):8612-8623. PubMed ID: 33016643
[TBL] [Abstract][Full Text] [Related]
18. Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway.
Pan Y; Cheung ST; Tong JHM; Tin KY; Kang W; Lung RWM; Wu F; Li H; Ng SSM; Mak TWC; To KF; Chan AWH
J Transl Med; 2018 Jun; 16(1):150. PubMed ID: 29866109
[TBL] [Abstract][Full Text] [Related]
19. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
20. Regorafenib suppresses epidermal growth factor receptor signaling-modulated progression of colorectal cancer.
Liu YC; Tsai JJ; Weng YS; Hsu FT
Biomed Pharmacother; 2020 Aug; 128():110319. PubMed ID: 32502841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
